{"id":"https://openalex.org/W2077872201","doi":"https://doi.org/10.1371/journal.pone.0020927","title":"A Directed Molecular Evolution Approach to Improved Immunogenicity of the HIV-1 Envelope Glycoprotein","display_name":"A Directed Molecular Evolution Approach to Improved Immunogenicity of the HIV-1 Envelope Glycoprotein","publication_year":2011,"publication_date":"2011-06-29","ids":{"openalex":"https://openalex.org/W2077872201","doi":"https://doi.org/10.1371/journal.pone.0020927","mag":"2077872201","pmid":"https://pubmed.ncbi.nlm.nih.gov/21738594","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3126809"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pone.0020927","doi":"https://doi.org/10.1371/journal.pone.0020927","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0020927","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0020927&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0020927&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109876819","display_name":"Sean X. Du","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118787663","display_name":"Maxygen (United States)","ror":"https://ror.org/00sqg3532","country_code":"US","type":"company","lineage":["https://openalex.org/I118787663"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sean X. Du","raw_affiliation_strings":["Department of Infectious Diseases, Maxygen, Inc., Redwood City, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Maxygen, Inc., Redwood City, California, United States of America","institution_ids":["https://openalex.org/I118787663"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Li Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118787663","display_name":"Maxygen (United States)","ror":"https://ror.org/00sqg3532","country_code":"US","type":"company","lineage":["https://openalex.org/I118787663"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Li Xu","raw_affiliation_strings":["Department of Infectious Diseases, Maxygen, Inc., Redwood City, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Maxygen, Inc., Redwood City, California, United States of America","institution_ids":["https://openalex.org/I118787663"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000013421","display_name":"Wenge Zhang","orcid":"https://orcid.org/0000-0002-6365-850X","observed_orcids":["https://orcid.org/0000-0002-6365-850X"]},"institutions":[{"id":"https://openalex.org/I118787663","display_name":"Maxygen (United States)","ror":"https://ror.org/00sqg3532","country_code":"US","type":"company","lineage":["https://openalex.org/I118787663"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wenge Zhang","raw_affiliation_strings":["Department of Infectious Diseases, Maxygen, Inc., Redwood City, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Maxygen, Inc., Redwood City, California, United States of America","institution_ids":["https://openalex.org/I118787663"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102184723","display_name":"Susan Tang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118787663","display_name":"Maxygen (United States)","ror":"https://ror.org/00sqg3532","country_code":"US","type":"company","lineage":["https://openalex.org/I118787663"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Tang","raw_affiliation_strings":["Department of Infectious Diseases, Maxygen, Inc., Redwood City, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Maxygen, Inc., Redwood City, California, United States of America","institution_ids":["https://openalex.org/I118787663"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051597529","display_name":"Rebecca I. Boenig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118787663","display_name":"Maxygen (United States)","ror":"https://ror.org/00sqg3532","country_code":"US","type":"company","lineage":["https://openalex.org/I118787663"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca I. Boenig","raw_affiliation_strings":["Department of Infectious Diseases, Maxygen, Inc., Redwood City, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Maxygen, Inc., Redwood City, California, United States of America","institution_ids":["https://openalex.org/I118787663"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051935412","display_name":"Helen Chen","orcid":"https://orcid.org/0000-0002-9401-7895","observed_orcids":["https://orcid.org/0000-0002-9401-7895"]},"institutions":[{"id":"https://openalex.org/I118787663","display_name":"Maxygen (United States)","ror":"https://ror.org/00sqg3532","country_code":"US","type":"company","lineage":["https://openalex.org/I118787663"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Helen Chen","raw_affiliation_strings":["Department of Infectious Diseases, Maxygen, Inc., Redwood City, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Maxygen, Inc., Redwood City, California, United States of America","institution_ids":["https://openalex.org/I118787663"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081061443","display_name":"Ellaine B. Mariano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118787663","display_name":"Maxygen (United States)","ror":"https://ror.org/00sqg3532","country_code":"US","type":"company","lineage":["https://openalex.org/I118787663"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ellaine B. Mariano","raw_affiliation_strings":["Department of Infectious Diseases, Maxygen, Inc., Redwood City, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Maxygen, Inc., Redwood City, California, United States of America","institution_ids":["https://openalex.org/I118787663"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055747549","display_name":"Michael B. Zwick","orcid":"https://orcid.org/0000-0002-0885-2502","observed_orcids":["https://orcid.org/0000-0002-0885-2502"]},"institutions":[{"id":"https://openalex.org/I123431417","display_name":"Scripps Research Institute","ror":"https://ror.org/02dxx6824","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I123431417"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael B. Zwick","raw_affiliation_strings":["Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, United States of America","institution_ids":["https://openalex.org/I123431417"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039190287","display_name":"Paul W.H.I. Parren","orcid":"https://orcid.org/0000-0002-4365-3859","observed_orcids":["https://orcid.org/0000-0002-4365-3859"]},"institutions":[{"id":"https://openalex.org/I123431417","display_name":"Scripps Research Institute","ror":"https://ror.org/02dxx6824","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I123431417"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul W. H. I. Parren","raw_affiliation_strings":["Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, United States of America","institution_ids":["https://openalex.org/I123431417"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058546353","display_name":"Dennis R. Burton","orcid":"https://orcid.org/0000-0001-6711-9864","observed_orcids":["https://orcid.org/0000-0001-6711-9864","https://orcid.org/0000-0002-8637-1405"]},"institutions":[{"id":"https://openalex.org/I123431417","display_name":"Scripps Research Institute","ror":"https://ror.org/02dxx6824","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I123431417"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2802422659","display_name":"Ragon Institute of MGH, MIT and Harvard","ror":"https://ror.org/053r20n13","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I2802422659","https://openalex.org/I4210087915","https://openalex.org/I48633490","https://openalex.org/I63966007"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennis R. Burton","raw_affiliation_strings":["Department of Immunology and Microbial Science, and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America","Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Boston, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology and Microbial Science, and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America","institution_ids":["https://openalex.org/I123431417"]},{"raw_affiliation_string":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Boston, Massachusetts, United States of America","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I2802422659","https://openalex.org/I4210087915","https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034553895","display_name":"Terri Wrin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Terri Wrin","raw_affiliation_strings":["Monogram Biosciences, San Francisco, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Monogram Biosciences, San Francisco, California, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042931433","display_name":"Christos J. Petropoulos","orcid":"https://orcid.org/0000-0001-5496-8090","observed_orcids":["https://orcid.org/0000-0001-5496-8090"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christos J. Petropoulos","raw_affiliation_strings":["Monogram Biosciences, San Francisco, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Monogram Biosciences, San Francisco, California, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049659081","display_name":"John A. Ballantyne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133695","display_name":"Aldevron (United States)","ror":"https://ror.org/03fq30e75","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133695","https://openalex.org/I57328836"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John A. Ballantyne","raw_affiliation_strings":["Aldevron LLC, Fargo, North Dakota, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aldevron LLC, Fargo, North Dakota, United States of America","institution_ids":["https://openalex.org/I4210133695"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072352798","display_name":"Michael James Chambers","orcid":"https://orcid.org/0000-0002-0658-6984","observed_orcids":["https://orcid.org/0000-0002-0658-6984"]},"institutions":[{"id":"https://openalex.org/I4210133695","display_name":"Aldevron (United States)","ror":"https://ror.org/03fq30e75","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133695","https://openalex.org/I57328836"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Chambers","raw_affiliation_strings":["Aldevron LLC, Fargo, North Dakota, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aldevron LLC, Fargo, North Dakota, United States of America","institution_ids":["https://openalex.org/I4210133695"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044081043","display_name":"Robert G. Whalen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118787663","display_name":"Maxygen (United States)","ror":"https://ror.org/00sqg3532","country_code":"US","type":"company","lineage":["https://openalex.org/I118787663"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Robert G. Whalen","raw_affiliation_strings":["Department of Infectious Diseases, Maxygen, Inc., Redwood City, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Maxygen, Inc., Redwood City, California, United States of America","institution_ids":["https://openalex.org/I118787663"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5044081043"],"corresponding_institution_ids":["https://openalex.org/I118787663"],"apc_list":{"value":2382,"currency":"USD","value_usd":2382},"apc_paid":{"value":2382,"currency":"USD","value_usd":2382},"fwci":1.2968,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.77831603,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"6","issue":"6","first_page":"e20927","last_page":"e20927"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10835","display_name":"Carbohydrate Chemistry and Synthesis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.8230000138282776},{"id":"https://openalex.org/keywords/gp120","display_name":"gp120","score":0.906000018119812},{"id":"https://openalex.org/keywords/hiv-1-envelope-glycoprotein","display_name":"HIV-1 envelope glycoprotein","score":0.8679999709129333},{"id":"https://openalex.org/keywords/directed-evolution","display_name":"directed evolution","score":0.8009999990463257},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.8799999952316284},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.7480000257492065},{"id":"https://openalex.org/keywords/hiv-1-vaccine","display_name":"HIV-1 vaccine","score":0.5580000281333923},{"id":"https://openalex.org/keywords/v3-loop","display_name":"V3 loop","score":0.7170000076293945},{"id":"https://openalex.org/keywords/antigenic-diversity","display_name":"antigenic diversity","score":0.5519999861717224},{"id":"https://openalex.org/keywords/dna-priming","display_name":"DNA priming","score":0.5680000185966492},{"id":"https://openalex.org/keywords/subtype-b","display_name":"subtype B","score":0.35600000619888306}],"concepts":[{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.8823082447052002},{"id":"https://openalex.org/C108625454","wikidata":"https://www.wikidata.org/wiki/Q187126","display_name":"Glycoprotein","level":2,"score":0.676472544670105},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6625152826309204},{"id":"https://openalex.org/C2779261636","wikidata":"https://www.wikidata.org/wiki/Q7003054","display_name":"Neutralizing antibody","level":3,"score":0.6029068827629089},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5389164090156555},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5257759094238281},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5159107446670532},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3176879286766052}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003412","descriptor_name":"Cricetulus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006224","descriptor_name":"Cricetinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008969","descriptor_name":"Molecular Sequence Data","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015483","descriptor_name":"HIV Antibodies","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015699","descriptor_name":"HIV Envelope Protein gp120","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015699","descriptor_name":"HIV Envelope Protein gp120","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015699","descriptor_name":"HIV Envelope Protein gp120","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016466","descriptor_name":"CHO Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019143","descriptor_name":"Evolution, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020349","descriptor_name":"Surface Plasmon Resonance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1371/journal.pone.0020927","doi":"https://doi.org/10.1371/journal.pone.0020927","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0020927","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0020927&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3126809","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3126809","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS One","raw_type":"Text"},{"id":"pmid:21738594","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21738594","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.785.3113","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.785.3113","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/1c/47/pone.0020927.PMC3126809.pdf","raw_type":"text"},{"id":"pmh:oai:doaj.org/article:8aeb5bb4d0ea428fa8ca3ec1ac121e60","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/8aeb5bb4d0ea428fa8ca3ec1ac121e60","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS ONE, Vol 6, Iss 6, p e20927 (2011)","raw_type":"article"},{"id":"pmh:oai:figshare.com:article/135508","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/A_Directed_Molecular_Evolution_Approach_to_Improved_Immunogenicity_of_the_HIV_1_Envelope_Glycoprotein/135508","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"}],"best_oa_location":{"id":"doi:10.1371/journal.pone.0020927","doi":"https://doi.org/10.1371/journal.pone.0020927","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0020927","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0020927&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.7246000170707703}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4198763198","display_name":"Human Antibodies to HIV-1 by Repertoire Cloning","funder_award_id":"R01AI033292","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G4252433980","display_name":"Development of Novel Immunogens for Vaccines to HIV-1","funder_award_id":"P01AI056375","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320306078","display_name":"U.S. Department of Defense","ror":"https://ror.org/0447fe631"},{"id":"https://openalex.org/F4320306138","display_name":"International AIDS Vaccine Initiative","ror":"https://ror.org/05ayv2203"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2077872201.pdf","grobid_xml":"https://content.openalex.org/works/W2077872201.grobid-xml"},"referenced_works_count":89,"referenced_works":["https://openalex.org/W1484767785","https://openalex.org/W1594804329","https://openalex.org/W1628484047","https://openalex.org/W1639694146","https://openalex.org/W1794879226","https://openalex.org/W1842798465","https://openalex.org/W1967050458","https://openalex.org/W1971233211","https://openalex.org/W1973581581","https://openalex.org/W1976163997","https://openalex.org/W1980696330","https://openalex.org/W1981664376","https://openalex.org/W1986103819","https://openalex.org/W1989464743","https://openalex.org/W1991112092","https://openalex.org/W1991436594","https://openalex.org/W1992566288","https://openalex.org/W1993366615","https://openalex.org/W1997677784","https://openalex.org/W1998371600","https://openalex.org/W2001256775","https://openalex.org/W2002146493","https://openalex.org/W2006483986","https://openalex.org/W2010996470","https://openalex.org/W2012515938","https://openalex.org/W2019866009","https://openalex.org/W2021803494","https://openalex.org/W2023422628","https://openalex.org/W2032211300","https://openalex.org/W2033142504","https://openalex.org/W2034020541","https://openalex.org/W2034160159","https://openalex.org/W2042610523","https://openalex.org/W2048719253","https://openalex.org/W2049108539","https://openalex.org/W2051364248","https://openalex.org/W2053410797","https://openalex.org/W2055253070","https://openalex.org/W2057961805","https://openalex.org/W2062204035","https://openalex.org/W2067107443","https://openalex.org/W2071086763","https://openalex.org/W2075371952","https://openalex.org/W2078412328","https://openalex.org/W2083726777","https://openalex.org/W2084310667","https://openalex.org/W2085662163","https://openalex.org/W2088423207","https://openalex.org/W2092620639","https://openalex.org/W2094829985","https://openalex.org/W2096387523","https://openalex.org/W2098781795","https://openalex.org/W2099047220","https://openalex.org/W2099308199","https://openalex.org/W2103038524","https://openalex.org/W2105841559","https://openalex.org/W2111675603","https://openalex.org/W2113822425","https://openalex.org/W2120161758","https://openalex.org/W2120653364","https://openalex.org/W2122475021","https://openalex.org/W2124359177","https://openalex.org/W2126817706","https://openalex.org/W2127146638","https://openalex.org/W2129274180","https://openalex.org/W2131317050","https://openalex.org/W2131974188","https://openalex.org/W2134123088","https://openalex.org/W2135151522","https://openalex.org/W2137939749","https://openalex.org/W2140457265","https://openalex.org/W2141444589","https://openalex.org/W2141514558","https://openalex.org/W2144539981","https://openalex.org/W2146396346","https://openalex.org/W2147925479","https://openalex.org/W2149653499","https://openalex.org/W2152048324","https://openalex.org/W2152399881","https://openalex.org/W2154642132","https://openalex.org/W2155429177","https://openalex.org/W2155922867","https://openalex.org/W2157210912","https://openalex.org/W2171790647","https://openalex.org/W2317426143","https://openalex.org/W2319526973","https://openalex.org/W4248734872","https://openalex.org/W4291255766","https://openalex.org/W6979007141"],"related_works":["https://openalex.org/W2090432085","https://openalex.org/W2887174992","https://openalex.org/W2902274984","https://openalex.org/W2093582005","https://openalex.org/W2171790647","https://openalex.org/W2150397848","https://openalex.org/W2072516660","https://openalex.org/W7009309967","https://openalex.org/W1967050458","https://openalex.org/W1970727231"],"abstract_inverted_index":{"A":[0],"prophylactic":[1],"vaccine":[2],"is":[3,27],"needed":[4],"to":[5,18,60,94,146],"slow":[6],"the":[7,14,88,127,147],"spread":[8],"of":[9,13,66,80,113,119,123,134],"HIV-1":[10,38,115],"infection.":[11],"Optimization":[12],"wild-type":[15],"envelope":[16,40],"glycoproteins":[17,41],"create":[19],"immunogens":[20],"that":[21,54,74,87,126],"can":[22,90],"elicit":[23],"effective":[24,135],"neutralizing":[25,62,92,104],"antibodies":[26,93],"a":[28,110,132],"high":[29],"priority.":[30],"Starting":[31],"with":[32,70,82],"ten":[33],"genes":[34],"encoding":[35],"subtype":[36],"B":[37],"gp120":[39,52,84],"and":[42,142],"using":[43],"in":[44],"vitro":[45],"homologous":[46],"DNA":[47,136],"recombination,":[48],"we":[49],"created":[50],"chimeric":[51],"variants":[53,67,85],"were":[55,68],"screened":[56],"for":[57],"their":[58],"ability":[59],"bind":[61],"monoclonal":[63],"antibodies.":[64],"Hundreds":[65],"identified":[69],"novel":[71,97],"antigenic":[72],"phenotypes":[73],"exhibit":[75],"considerable":[76],"sequence":[77],"diversity.":[78],"Immunization":[79],"rabbits":[81],"these":[83],"demonstrated":[86],"majority":[89],"induce":[91],"HIV-1.":[95],"One":[96],"variant,":[98],"called":[99],"ST-008,":[100],"induced":[101],"significantly":[102],"improved":[103,144],"antibody":[105],"responses":[106],"when":[107],"assayed":[108],"against":[109],"large":[111],"panel":[112],"primary":[114],"isolates.":[116],"Further":[117],"study":[118],"various":[120],"deletion":[121],"constructs":[122],"ST-008":[124],"showed":[125],"enhanced":[128,139],"immunogenicity":[129],"results":[130],"from":[131],"combination":[133],"priming,":[137],"an":[138,143],"V3-based":[140],"response,":[141],"response":[145],"constant":[148],"backbone":[149],"sequences.":[150]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}